Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideaki Ogiwara

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Scientific Reports|December 29, 2024
Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cellsMariko Sasaki, Hideaki Ogiwara
Plos One|January 4, 2013
CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genesHideaki Ogiwara, Takashi Kohno
Cancer Science|January 20, 2020
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancersMariko Sasaki, Hideaki Ogiwara
Plos One|December 24, 2011
Essential factors for incompatible DNA end joining at chromosomal DNA double strand breaks in vivoHideaki Ogiwara, Takashi Kohno
Cell Cycle (Georgetown, Tex.)|May 2, 2007
The INO80 chromatin remodeling complex functions in sister chromatid cohesionHideaki Ogiwara, Takemi Enomoto, Masayuki Seki
Molecular Cancer Research : MCR|February 27, 2026
ARID1A Deficiency in Diffuse-Type Gastric Cancer Promotes a Pyrimidine Metabolic VulnerabilityHarumi Hirano, Hideki Makinoshima, Hideaki Ogiwara
Nucleic Acids Research|December 16, 2006
Role of Elg1 protein in double strand break repairHideaki Ogiwara, Ayako Ui, Takemi Enomoto, et al.
Journal of Radiation Research|February 14, 2014
Chromatin-regulating proteins as targets for cancer therapyTakahiro Oike, Hideaki Ogiwara, Napapat Amornwichet, et al.
NPJ Precision Oncology|March 13, 2025
Targeting USP8 causes synthetic lethality through degradation of FGFR2 in ARID1A-deficient ovarian clear cell carcinomaRyosuke Saito, Makoto Fukushima, Mariko Sasaki, et al.
Cancer Research|March 15, 2026
A GCLC Inhibitor Enhances the Antitumor Efficacy of Glutathione Metabolic Pathway Inhibition in SMARCB1-Deficient Rhabdoid TumorsMariko Takeuchi, Yoshinori Ishikawa, Takuya Okada, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Scientific Reports|December 29, 2024
Efficacy of glutathione inhibitor eprenetapopt against the vulnerability of glutathione metabolism in SMARCA4-, SMARCB1- and PBRM1-deficient cancer cellsMariko Sasaki, Hideaki Ogiwara
Plos One|January 4, 2013
CBP and p300 histone acetyltransferases contribute to homologous recombination by transcriptionally activating the BRCA1 and RAD51 genesHideaki Ogiwara, Takashi Kohno
Cancer Science|January 20, 2020
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex-deficient cancersMariko Sasaki, Hideaki Ogiwara
Plos One|December 24, 2011
Essential factors for incompatible DNA end joining at chromosomal DNA double strand breaks in vivoHideaki Ogiwara, Takashi Kohno
Cell Cycle (Georgetown, Tex.)|May 2, 2007
The INO80 chromatin remodeling complex functions in sister chromatid cohesionHideaki Ogiwara, Takemi Enomoto, Masayuki Seki
Molecular Cancer Research : MCR|February 27, 2026
ARID1A Deficiency in Diffuse-Type Gastric Cancer Promotes a Pyrimidine Metabolic VulnerabilityHarumi Hirano, Hideki Makinoshima, Hideaki Ogiwara
Nucleic Acids Research|December 16, 2006
Role of Elg1 protein in double strand break repairHideaki Ogiwara, Ayako Ui, Takemi Enomoto, et al.
Journal of Radiation Research|February 14, 2014
Chromatin-regulating proteins as targets for cancer therapyTakahiro Oike, Hideaki Ogiwara, Napapat Amornwichet, et al.
NPJ Precision Oncology|March 13, 2025
Targeting USP8 causes synthetic lethality through degradation of FGFR2 in ARID1A-deficient ovarian clear cell carcinomaRyosuke Saito, Makoto Fukushima, Mariko Sasaki, et al.
Cancer Research|March 15, 2026
A GCLC Inhibitor Enhances the Antitumor Efficacy of Glutathione Metabolic Pathway Inhibition in SMARCB1-Deficient Rhabdoid TumorsMariko Takeuchi, Yoshinori Ishikawa, Takuya Okada, et al.
Pageof 5